Contemporary treatment of types 2 diabetes regularly involves the use of SGLT2 inhibitors. There is now interest in using this medication for type 1 diabetes alongside insulin treatment. T1D patient input is critical in understanding how and when the use of SGLT2 inhibitors is considered acceptable. We wish to explore the thoughts and perspectives of T1D patients about all the factors they would need to consider before starting this medication, including any risks or benefits they anticipate.